Neuroimaging Findings during Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS) - a CAR T Cell Neurotoxicity Imaging Virtual Archive (CARNIVAL) Study
Haneen Shalabi(Center for Cancer Research), Juliane Gust(University of Washington), Arastoo Vossough(Children's Hospital of Philadelphia), Aimee C. Talleur(St. Jude Children's Research Hospital), Cynthia Harrison(National Institutes of Health), Dickson T. Chen(Seattle Children's Hospital), Rebecca Epperly(St. Jude Children's Research Hospital), Emily M. Hsieh(Children's Hospital of Los Angeles), Aiman Faruqi(National Cancer Institute), Swati Naik(St. Jude Children's Research Hospital), Agne Taraseviciute(Seattle Children's Hospital), Jennifer L. McGuire(NHS Lothian), Jason N. Wright(Seattle Children's Hospital), Jacob Taylor(University of Utah), Aashim Bhatia(Children's Hospital of Philadelphia), Caroline Diorio(Children's Hospital of Philadelphia), Rebecca Gardner(Seattle Children's Hospital), Murat Alp Öztek(University of Washington), Regina M. Myers(Children's Hospital of Philadelphia), Colleen Annesley(Unknown), Naomi Torres Carapia(Children's Hospital of Los Angeles), Yasmine Kotb(National Cancer Institute), Ritu Shah(The University of Texas MD Anderson Cancer Center), Greg Dolan(University of Utah), Kristi Lee Russell(University of Utah), Soniya Pinto(St. Jude Children's Research Hospital)
Cited by 5
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Evidence for 28 genetic disorders discovered by combining healthcare and research data
|Nature|2020|672
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
|Journal of Clinical Oncology|2020|422
CD19 CAR T cell product and disease attributes predict leukemia remission durability
|Journal of Clinical Investigation|2019|355